A novel model-based approach for dose determination of glycopyrronium bromide in COPD
about
Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease.Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.Long-acting muscarinic antagonists.Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study.Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach.Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).
P2860
Q26777927-82D3BCD5-CC15-48C0-ACF9-F0A6823A3F45Q37003186-6DE05CBD-805F-4DDD-8A2C-448ACF30E12EQ38057220-0758BAA2-0AB7-49C5-AE79-4F2792FC064AQ38107178-EE57564C-2EF9-4323-88D0-5E6DB347FFB7Q38131050-BA8375D4-EE8B-4606-8C38-C4CA6EFE169FQ38371555-B9A7546B-22B3-4CDB-83E7-2B2A9565C1F0Q38537326-4CB9EB60-BDA1-46FA-9518-F071445EBFE2Q38604641-F7F4BDFE-AE3D-4333-A555-50D31BD1C361Q41018618-479F0212-DA57-4F9A-BB83-B2B76EE7160FQ42858000-45780F63-2F3E-475F-B419-E64893E99F05Q55387524-CEEA75B4-5031-4F63-9260-9EE1DDD40507Q55430075-7A338625-C818-48B6-B931-C1A7C9F02B5B
P2860
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@ast
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@en
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@nl
type
label
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@ast
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@en
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@nl
prefLabel
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@ast
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@en
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@nl
P2093
P2860
P356
P1476
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
@en
P2093
Didier Renard
Donald Banerji
Helen Arievich
Michael Gibbs
Michael Looby
Tim Overend
Vijay Alagappan
P2860
P2888
P356
10.1186/1471-2466-12-74
P577
2012-12-08T00:00:00Z
P5875
P6179
1047955631